Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM)

CUSIP: 690145107

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
18,527,213
Total 13F shares
34,734
Share change
+10,134
Total reported value
$667,997
Price per share
$21.73
Number of holders
2
Value change
+$195,729
Number of buys
2
Number of sells
1

Security key

690145107

Report period

Q2 2025

Institutions

2

Top holders

2

Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13D/G 13F
Company
14%
2,596,861
$30,149,556 $0 31 Mar 2025
Durable Capital Partners LP
13D/G 13F
Company
9.9%
26,609,101
$154,630,808 $0 03 Jan 2025
Woodline Partners LP
13D/G 13F
Company
7.5%
1,325,784
$15,392,352 $0 31 Mar 2025
PERCEPTIVE ADVISORS LLC
13D/G 13F
Company
6.7%
1,208,334
$14,028,758 $0 31 Mar 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
5.6%
991,429
$18,919,737 $0 30 Jun 2025
Hackett Patrick T.
3/4/5
Director
1.2%
220,171
$3,368,614 02 Jun 2025
Renee Gaeta
3/4/5
Chief Financial Officer
0.73%
131,425
$2,010,802 10 Jun 2025
Brent D. Lang
3/4/5
Director
0.19%
34,517
$528,109 02 Jun 2025
D. Keith Grossman
3/4/5
Director
0.15%
26,763
$409,473 02 Jun 2025
Kevin C. Oboyle
3/4/5
Director
0.13%
24,118
$369,005 02 Jun 2025
Nabeel Ahmed
3/4/5
Chief Financial Officer
0.09%
16,096
$286,669 15 May 2025
Andrea Lynn Saia
3/4/5
Director
0.07%
12,175
$186,277 02 Jun 2025
Alyeska Investment Group, L.P.
13F
Company
9.4%
1,703,083
$18,836,098 31 Mar 2025
13F
PFM Health Sciences, LP
13F
Company
9.3%
1,685,727
$18,644,141 31 Mar 2025
13F
T. Rowe Price Investment Management, Inc.
13F
Company
8.8%
1,603,056
$17,730,000 31 Mar 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
4.6%
840,248
$9,293,143 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
3.6%
650,264
$7,191,919 31 Mar 2025
13F
Parkman Healthcare Partners LLC
13F
Company
1.3%
231,099
$2,555,955 31 Mar 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
1%
190,156
$2,103,123 31 Mar 2025
13F
Catalio Capital Management, LP
13F
Company
0.92%
166,666
$1,843,326 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.64%
115,061
$1,272,575 31 Mar 2025
13F
GMT CAPITAL CORP
13F
Company
0.54%
98,108
$1,085,074 31 Mar 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.49%
89,299
$985,000 31 Mar 2025
13F
Ensign Peak Advisors, Inc
13F
Company
0.47%
84,457
$934,094 31 Mar 2025
13F
C WorldWide Group Holding A/S
13F
Company
0.37%
66,666
$737,000 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.36%
65,918
$729,048 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.36%
64,694
$715,525 31 Mar 2025
13F
TD ASSET MANAGEMENT INC
13F
Company
0.29%
53,267
$589,129 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.23%
41,206
$455,738 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.22%
39,356
$435,534 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.19%
33,912
$375,067 31 Mar 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.15%
27,381
$303,000 31 Mar 2025
13F
Birchview Capital, LP
13F
Company
0.13%
24,584
$271,899 31 Mar 2025
13F
STIFEL FINANCIAL CORP
13F
Company
0.13%
22,978
$254,135 31 Mar 2025
13F
Squarepoint Ops LLC
13F
Company
0.12%
20,992
$232,172 31 Mar 2025
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0.1%
17,602
$194,502 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.09%
16,288
$180,145 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.09%
15,461
$170,999 31 Mar 2025
13F
HRT FINANCIAL LP
13F
Company
0.08%
14,818
$163,000 31 Mar 2025
13F
UBS Group AG
13F
Company
0.07%
12,101
$133,837 31 Mar 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.07%
12,028
$133,030 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
5,419
$59,934 31 Mar 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.03%
5,043
$55,000 31 Mar 2025
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.03%
5,000
$783,417 31 Mar 2025
13F
HUNTINGTON NATIONAL BANK
13F
Company
0.02%
3,820
$42,249 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.02%
2,839
$31,399 31 Mar 2025
13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
13F
Company
0.02%
2,810
$31,000 31 Mar 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.01%
1,160
$12,830 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
1,108
$12,255 31 Mar 2025
13F
Centricity Wealth Management, LLC
13F
Company
0%
563
$6,227 31 Mar 2025
13F

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) as of Q2 2025

As of 30 Jun 2025, Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,734 shares. The largest 2 holders included Birchview Capital, LP and Accent Capital Management, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
2
Q2 2025 holders
2
Holder diff
0
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .